News

NEW: PI Proxy Approval of Coverage Analysis & Budget

May 09, 2024
We are excited to announce a new opportunity for Principal Investigators to delegate the approval of study Coverage Analysis (CA) and/or budgets to qualified study team members who have completed the requisite advanced training courses.

Introducing OCTA’s Newly Reorganized Activation Teams!

March 18, 2024
Exciting news from the Office of Clinical Trial Activation (OCTA)! We've revamped our Activation Teams to better suit our evolving goals and objectives.   We are pleased to introduce our newly updated teams:  

OCTA Announces Additional Training Resources

February 14, 2024
OCTA announces additional training resources: Check out new OnCore Quick Guides supporting current clinical research workflows and post-award OnCore Financials workflows. More coming soon.

OCTA Leadership Announcement

January 08, 2024
 The Office of Clinical Trial Activation (OCTA) is excited to announce that James Sulahian has accepted the role of OnCore Manager effective January 14, 2024.

Important Updates: Office of Clinical Trial Activation - January 2024 Changes

December 20, 2023
Dear Clinical Research Community,  

OCTA Coverage Analysis (CA) Determination Form is Live!

December 07, 2023
The CA Determination Form is a tool that study teams can use prior to submitting their studies to OCTA to determine whether Coverage Analysis is required. For more information on Coverage Analysis, please visit the Coverage Analysis section of our website.

New Policy Coming - OnCore Utilization and APeX Billing Review for Clinical Trials

November 07, 2023
On behalf of the Office of Research, we would like to inform the UCSF Research Community of a new policy coming: OnCore Utilization and APeX Billing Review in Clinical Trials. This initiative is designed to ensure compliance with regulatory requirements, improve financial transparency, and promote ...

OCTA Staff Announcement

November 07, 2023
The Office of Clinical Trial Activation (OCTA) is excited to announce that Nick Wilson accepted the role of Clinical Trials Activation Manager.

OCTA 2023-2024 Holiday Schedule

October 17, 2023
OCTA 2023-2024 HOLIDAY SCHEDULE NEW CLINICAL TRIAL ACTIVATION DEADLINES & ONCORE SUPPORT

OCTA Staff Promotion Announcements

October 04, 2023
The Office of Clinical Trial Activation is excited to announce that Erin Breed accepted the inaugural role of Associate Director, Operation & Strategy, and Janna Blaauw accepted the role of Clinical Trials Activation Manager.

Pages